Novo Nordisk’s Wegovy linked to reduced food noise in real-world studies

• Novo Nordisk presented real-world study results linking Wegovy injection and pills to reduced intrusive food thoughts at ObesityWeek 2026.
• SIGNAL found reductions within the first month of injections, sustained through six months.
• OCTANE showed reduced food-related thoughts over three months with oral semaglutide; most participants reported treatment improvements.
• The observational studies suggest potential benefits beyond weight loss but cannot establish causality.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Novo Nordisk A/S published the original content used to generate this news brief on November 14, 2026, and is solely responsible for the information contained therein.